LifeVantage Further Enhances Management Team with Appointment of Steven R. Fife as Chief Financial Officer
March 13 2017 - 9:00AM
LifeVantage Corporation (Nasdaq:LFVN), announced today the
appointment of Steven R. Fife as Chief Financial Officer, effective
immediately.
“As part of our ongoing commitment to enhance our management
team, I am delighted to bring Steve Fife on board as CFO,” said
LifeVantage President and Chief Executive Officer, Darren Jensen.
“Attracting someone of Steve’s caliber is a testament to the
opportunities available at LifeVantage. Not only does he have
substantial public company experience, he brings a diverse
financial perspective, with experience with high growth companies,
cost saving initiatives, redesigns of internal productivity systems
and establishing strong environments of processes and controls.
Steve also has significant international experience, providing
experience in Asia to support our near-term and long-term goals in
this promising region. He will be instrumental in refining and
implementing our growth strategy, executing our goals, driving
value to our shareholders and guiding our company to long-term
growth.”
“It is truly an exciting time to join the LifeVantage team and
have the opportunity to better leverage the Company’s strong
positioning with proprietary science-based products and a powerful
distribution channel,” said Fife. “I look forward to
contributing to the accelerated efforts to build the Company’s
infrastructure, enhance working capital management and institute
the processes and controls to support profitable global growth.
Mr. Fife has more than three decades of financial and leadership
experience having served in several C-level financial and
leadership roles. Most recently, Mr. Fife served from 2014 to 2016
as Chief Financial Officer and Chief Operating Officer at Evidera,
Inc., a private equity sponsored professional services firm that
provides outcomes research, market access, data analytics and
epidemiology services to pharmaceutical companies. While at
Evidera, Mr. Fife led multiple international teams, was responsible
for implementing cost optimization initiatives and infrastructure
process and system improvements, building the infrastructure to
support merger and acquisition activity and driving EBITDA growth,
leading to the successful sale of the company.
Prior to joining Evidera, Inc., Mr Fife’s experience includes
serving as Chief Financial Officer for publicly traded companies,
including Active Power, Inc. and LECG. In addition, he served in
several senior financial roles for Gilead Sciences, Amkor
Technologies and JDS Uniphase. He also served as Interim Chief
Financial Officer for a non-profit organization, Women’s Initiative
for Self Employment. Mr. Fife began his accounting and
finance career with Deloitte & Touche. Mr. Fife is a Certified
Public Accountant (inactive) in the State of California and holds a
Bachelor of Science degree in Accounting from Brigham Young
University.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq:LFVN), is a science-based direct
selling company dedicated to visionary science that looks to
transform health, wellness and anti-aging internally and externally
at the cellular level. The company is the maker of Protandim ® Nrf2
and NRF1 Synergizers, its line of scientifically-validated dietary
supplements, the TrueScience® Anti-Aging Skin Care Regimen, Canine
Health®, the AXIO® energy product line and the PhysIQ™ Smart Weight
Management System. LifeVantage was founded in 2003 and is
headquartered in Salt Lake City, Utah.
www.lifevantage.com
Forward Looking Statements
This document contains forward-looking statements made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Words and expressions reflecting optimism,
satisfaction or disappointment with current prospects, as well as
words such as "believe", "hopes", "intends", "estimates",
"expects", "projects", "plans", "anticipates", "look forward to",
"goal", "may be", "should", and variations thereof, identify
forward-looking statements, but their absence does not mean that a
statement is not forward-looking. Examples of forward-looking
statements include, but are not limited to, statements we make
regarding our leadership transition, future growth, and shareholder
value. Such forward-looking statements are not guarantees of
performance and the Company's actual results could differ
materially from those contained in such statements. These
forward-looking statements are based on the Company's current
expectations and beliefs concerning future events affecting the
Company and involve known and unknown risks and uncertainties that
may cause the Company's actual results or outcomes to be materially
different from those anticipated and discussed herein. These risks
and uncertainties include, among others, those discussed in greater
detail in the Company's Annual Report on Form 10-K and the
Company's Quarterly Report on Form 10-Q under the caption "Risk
Factors," and in other documents filed by the Company from time to
time with the Securities and Exchange Commission. The Company
cautions investors not to place undue reliance on the
forward-looking statements contained in this document. All
forward-looking statements are based on information currently
available to the Company on the date hereof, and the Company
undertakes no obligation to revise or update these forward-looking
statements to reflect events or circumstances after the date of
this document, except as required by law.
Investor Relations Contacts:
Cindy England
Director of Investor Relations
(801) 432-9036
investor@lifevantage.com
-or-
Scott Van Winkle
Managing Director, ICR
(617) 956-6736
scott.vanwinkle@icrinc.com
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Apr 2023 to Apr 2024